Professor Ian Meredith is Executive Vice President and Global Chief Medical Officer for Boston Scientific and a member of the Executive Committee. In this role, he is responsible for leading clinical and medical affairs across Boston Scientific and providing global leadership of the company’s clinical trial strategy.
Prior to joining Boston Scientific in 2017, Professor Meredith served as Professor and Director of MonashHeart, the Cardiology service within Monash Health in Melbourne, Australia and one of the largest cardiac care services in Australia. He was also Professor of Medicine and Cardiology at Monash University in Melbourne and Executive Director of the Monash Cardiovascular Research Centre at Monash University.
With more than 25 years of experience as a clinical and interventional cardiologist, Professor Meredith has performed more than 12,000 invasive cardiac and coronary procedures, published more than 350 peer-reviewed manuscripts and book chapters and championed many new treatment paradigms into daily clinical practice. He has been the chief or principal investigator on more than 50 major international multi-center trials and was the global principal investigator for the Boston Scientific Lotus™ Valve REPRISE research program.
Professor Meredith has served on numerous national and international professional boards, government committees and advisory boards including the Department of Health and Human Services., Cardiac Services Review and the Federal Government Department of Health & Aging Cardiac Prostheses Advisory Group. He received an Order of Australia (AM) for outstanding service to medicine in the field of Cardiology as a clinician and researcher and through advisory roles with a range of public health and organizations.
Professor Meredith completed his undergraduate medical education in Melbourne and his PhD at the Baker Institute before embarking on post-graduate training at the Brigham and Women’s Hospital and Harvard Medical School in Boston.